Elizabeth O'Farrell
Net worth: 1 M $ as of 30/01/2026
Net worth: 1 M $ as of 30/01/2026
Elizabeth G.
O'Farrell is currently Chairman at Geron Corp.
since 2025, Chairman at PDL BioPharma, Inc. since 2020, Independent Director at LENSAR, Inc. since 2021, Independent Director at SpyGlass Pharma, Inc. since 2025, Independent Director at Genmab A since 2022, and Director at Karius, Inc. since 2023.
Former roles include Chief Financial Officer & Executive Director at Eli Lilly Canada, Inc., Director at Washington Township Schools Foundation from 2003 to 2010, Independent Director at Inhibikase Therapeutics, Inc. from 2019 to 2022, Director at Keep Indianapolis Beautiful, Inc., Director at Y.M.C.A. Foundation of Greater Indianapolis from 2016 to 2017, Chief Procurement Officer at Eli Lilly & Co. from 2012 to 2017, Accountant at OfficeMax Contract, Inc., Auditor at Pricewaterhouse LLP, Auditor at Whipple & Co., Manager at Somerset Financial Services LLC, and Chief Financial Officer, SVP-Policy & Finance at Lilly USA LLC.
Education includes an MBA conferred in 1987 and an undergraduate degree conferred in 1986, both from Indiana University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/02/2026 | 1,885 ( 0% ) | 607 193 $ | 30/01/2026 | |
LENSAR INC 0.36% | 23/10/2025 | 42,573 ( 0.36% ) | 541 954 $ | 30/01/2026 |
GERON CORPORATION 0.01% | 20/05/2025 | 33,627 ( 0.01% ) | 46 069 $ | 30/01/2026 |
| 04/02/2026 | 0 ( -.--% ) | - $ | 30/01/2026 |
| Companies | Position | Start |
|---|---|---|
| PDL BIOPHARMA, INC. | Chairman | 31/12/2019 |
| GERON CORPORATION | Chairman | 11/03/2025 |
| LENSAR, INC. | Director/Board Member | 31/01/2021 |
| GENMAB A/S | Director/Board Member | 28/03/2022 |
| SPYGLASS PHARMA, INC. | Director/Board Member | 31/07/2025 |
Karius, Inc.
Karius, Inc. Medical/Nursing ServicesHealth Services Operates as clinical and medical research laboratory to improve the diagnosis & treatment of infectious diseases for hospitals and physicians | Director/Board Member | 09/08/2023 |
| Companies | Position | End |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 31/08/2022 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 30/11/2017 |
Y.M.C.A. Foundation of Greater Indianapolis
Y.M.C.A. Foundation of Greater Indianapolis Miscellaneous Commercial ServicesCommercial Services Provides wellness programs | Chairman | 31/12/2016 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 18 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
OfficeMax Contract, Inc.
OfficeMax Contract, Inc. Forest ProductsNon-Energy Minerals Makes paper, office and building products | Non-Energy Minerals |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
LENSAR, Inc.
LENSAR, Inc. Medical SpecialtiesHealth Technology Develops femtosecond laser technologies for refractive cataract surgery | Health Technology |
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Pricewaterhouse LLP
Pricewaterhouse LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Health Technology |
Whipple & Co.
Whipple & Co. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Somerset Financial Services LLC
Somerset Financial Services LLC Investment ManagersFinance Provides financial services | Finance |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Washington Township Schools Foundation | |
Lilly USA LLC
Lilly USA LLC Pharmaceuticals: MajorHealth Technology Lilly USA LLC engages in the provision of pharmaceutical services. The company was founded on July 15, 2008 and is headquartered in Indianapolis, IN. | Health Technology |
Y.M.C.A. Foundation of Greater Indianapolis
Y.M.C.A. Foundation of Greater Indianapolis Miscellaneous Commercial ServicesCommercial Services Provides wellness programs | Commercial Services |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Karius, Inc.
Karius, Inc. Medical/Nursing ServicesHealth Services Operates as clinical and medical research laboratory to improve the diagnosis & treatment of infectious diseases for hospitals and physicians | Health Services |
Keep Indianapolis Beautiful, Inc.
Keep Indianapolis Beautiful, Inc. Miscellaneous Commercial ServicesCommercial Services Keep Indianapolis Beautiful, Inc. (KIB) is an environmental and community nonprofit organization based in Indianapolis. KIB aims to create vibrant public spaces to help people and nature thrive. As an affiliate of Keep America Beautiful, Inc., KIB works with neighbors and volunteers to plant trees and native landscapes, create community spaces, pick up litter, and engage learners of all ages in nature. With over 40 years of experience, KIB supports over 800 community projects each year with nearly 20,000 volunteers. The organization partners with neighbors, the public sector, and community groups and businesses to achieve their vision of a beautiful city. Jeremy Kranowitz has been the CEO of the company since 2019. | Commercial Services |
SpyGlass Pharma Inc
SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition